Brendan T McKeown

5PUBLICATIONS
4CO-AUTHORS
Molecular targetsChemotherapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Mar 06, 2025
Systematic review of Health Canada approved clinical therapeutic trials for the treatment or prevention of coronavirus disease 2019 (COVID-19).

Antonios M Diab, Hailey M Stack, Brendan T McKeown

|Oct 31, 2024
Pharmacological interactions of jadomycin B with topoisomerase poisons in MDA-MB-231 human breast cancer cells.

Brendan T McKeown, Kerry B Goralski

|Feb 27, 2023
Correction: Pilot study of jadomycin B pharmacokinetics and anti-tumoral effects in zebrafish larvae and mouse breast cancer xenograft models.

Brendan T McKeown, Nicholas J Relja, Steven R Hall

|Aug 19, 2022
Pilot study of jadomycin B pharmacokinetics and anti-tumoral effects in zebrafish larvae and mouse breast cancer xenograft models.

Brendan T McKeown, Nicholas J Relja, Steven R Hall

|Oct 28, 2021
Jadomycins: A potential chemotherapy for multi-drug resistant metastatic breast cancer.

Esther P Bonitto, Brendan T McKeown, Kerry B Goralski

Pageof 1